APA (7th ed.) Citation

BL, R., K, J., JA, B., A, T., C, B., JS, H., . . . HJ, S. (2010). Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: A randomized, double-blind study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 18(4), 423. https://doi.org/10.1007/s00520-009-0680-9

Chicago Style (17th ed.) Citation

BL, Rapoport, Jordan K, Boice JA, Taylor A, Brown C, Hardwick JS, Carides A, Webb T, and Schmoll HJ. "Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting Associated with a Broad Range of Moderately Emetogenic Chemotherapies and Tumor Types: A Randomized, Double-blind Study." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 18, no. 4 (2010): 423. https://doi.org/10.1007/s00520-009-0680-9.

MLA (9th ed.) Citation

BL, Rapoport, et al. "Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting Associated with a Broad Range of Moderately Emetogenic Chemotherapies and Tumor Types: A Randomized, Double-blind Study." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 18, no. 4, 2010, p. 423, https://doi.org/10.1007/s00520-009-0680-9.